Method Validation [Bioanalytics]

posted by Loky do – Egypt, 2025-03-13 12:19 (118 d 11:51 ago) – Posting: # 24386
Views: 2,617

Dears
Appreciate your advice
What are the potential implications of mistakenly designing the QC high at 70% of the upper limit and analyzing study samples based on this? Would re-validation and reanalysis of all samples be required, or could this deviation be accepted by regulatory authorities?

Thanks in Advance
LD

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,693 registered users;
30 visitors (0 registered, 30 guests [including 9 identified bots]).
Forum time: 01:11 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5